AU5863694A - Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation - Google Patents

Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation

Info

Publication number
AU5863694A
AU5863694A AU58636/94A AU5863694A AU5863694A AU 5863694 A AU5863694 A AU 5863694A AU 58636/94 A AU58636/94 A AU 58636/94A AU 5863694 A AU5863694 A AU 5863694A AU 5863694 A AU5863694 A AU 5863694A
Authority
AU
Australia
Prior art keywords
apan
brl55730
amidinophenyl
ester
complement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58636/94A
Other languages
English (en)
Inventor
Danuta Ewa Irena Mossakowska
Richard Anthony Godwin Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU5863694A publication Critical patent/AU5863694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU58636/94A 1993-01-22 1994-01-21 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation Abandoned AU5863694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9301289 1993-01-22
GB939301289A GB9301289D0 (en) 1993-01-22 1993-01-22 Novel composition
PCT/GB1994/000122 WO1994016719A1 (en) 1993-01-22 1994-01-21 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation

Publications (1)

Publication Number Publication Date
AU5863694A true AU5863694A (en) 1994-08-15

Family

ID=10729169

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58636/94A Abandoned AU5863694A (en) 1993-01-22 1994-01-21 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation

Country Status (10)

Country Link
EP (1) EP0680332A1 (enExample)
JP (1) JPH08505867A (enExample)
CN (1) CN1118141A (enExample)
AU (1) AU5863694A (enExample)
CA (1) CA2153797A1 (enExample)
GB (1) GB9301289D0 (enExample)
NZ (1) NZ259737A (enExample)
TW (1) TW241203B (enExample)
WO (1) WO1994016719A1 (enExample)
ZA (1) ZA94398B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT724435E (pt) * 1993-10-21 2002-11-29 Searle & Co Derivados amidino uteis como inibidores de oxido nitrico sintase
GB9604518D0 (en) * 1996-03-02 1996-05-01 Smithkline Beecham Plc Novel compounds
US8088386B2 (en) * 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
JP4897690B2 (ja) * 2004-10-12 2012-03-14 ジェネンテック， インコーポレイテッド 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド
GB201800620D0 (en) 2018-01-15 2018-02-28 Univ Manchester C3b Binding Polypeptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
DE3207033C2 (de) * 1981-02-27 1984-09-13 Torii & Co., Ltd., Tokyo Amidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
JPS57179147A (en) * 1981-04-28 1982-11-04 Torii Yakuhin Kk Amidine derivative
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
WO1992010205A1 (en) * 1990-12-06 1992-06-25 T Cell Sciences, Inc. Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity

Also Published As

Publication number Publication date
CA2153797A1 (en) 1994-08-04
CN1118141A (zh) 1996-03-06
TW241203B (enExample) 1995-02-21
NZ259737A (en) 1997-04-24
ZA94398B (en) 1994-11-15
GB9301289D0 (en) 1993-03-17
WO1994016719A1 (en) 1994-08-04
JPH08505867A (ja) 1996-06-25
EP0680332A1 (en) 1995-11-08

Similar Documents

Publication Publication Date Title
US7241783B2 (en) Thrombopoietin mimetics
EP0661992B1 (en) Pharmaceutical formulations of interleukin-1 inhibitors
EP2371857A1 (en) Factor XII inhibitors for treating interstitial lung disease
AU9149791A (en) Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
US6720345B1 (en) Semicarbazone derivatives and their use as thrombopoietin mimetics
AU5863694A (en) Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation
US20120020923A1 (en) Method of treating viral diseases with combinations of TPO receptor agonist and anti-viral agents
US6335330B1 (en) Crystalline pharmaceutical product
WO2010129738A1 (en) Method of treating thrombocytopenia
US8476249B2 (en) Method of treating thrombocytopenia
US20050042202A1 (en) Compositions for and methods of treating and preventing sirs/sepsis
WO2002011725A1 (en) Inflammatory cytokine production inhibitors
KR20090120350A (ko) 니코틴산 아데닌 디뉴클레오티드 인산 또는 그 유도체의 제2형 당뇨병 치료제로서의 용도
JPH03133927A (ja) 虚血後の心筋機能障害の改善剤
Enkhbaatar et al. Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide
AU2270399A (en) Use of substituted amidino compounds in the treatment of chronic obstructive pulmonary disease
US20040097583A1 (en) Use of inhibitors of the sodium/hydrogen exchanger for the treatment of thrombotic and inflammatory disorders
WO2004035048A1 (ja) 肝繊維化抑制剤
JPWO2009028573A1 (ja) 血液凝固障害におけるリバビリンの利用
JPH07267857A (ja) 新規な炎症細胞の活性化抑制剤
JP2000007562A (ja) レトロウイルス感染に伴う免疫不全発症予防薬及び進行抑制薬
KR20140038210A (ko) 아나그렐리드를 포함하는 류마티스 관절염의 예방 또는 치료용 약학 조성물
CZ20002135A3 (cs) Substituované amidinové sloučeniny a jejich použití při léčení chronického obstrukčního plicního onemocnění